AI Governance: Plans in Place?
Implementation of AI governance is imperative for excellent patient care.
Read moreThe U.S. Food and Drug Administration (FDA) seeks public comments on draft guidance it published Jan. 7. Of particular interest to the American College of Radiology® (ACR®) is “Artificial Intelligence (AI)-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations.”
The industry guidance outlines a total product lifecycle (TPLC) approach to risk management of AI device software functions, as well as related documentation to support FDA review. It also provides recommendations relevant to transparency and bias mitigation throughout the TPLC, including within the product’s user interface and labelling.
The ACR Informatics Commission and Data Science Institute® (DSI) leadership are reviewing the guidance. The College’s initiatives related to AI are on the DSI website.
Public comments are due to the FDA by April 7.
If you have questions or would like more information about ACR AI/digital health policy, contact Michael Peters, ACR Senior Director, Government Affairs.
AI Governance: Plans in Place?
Implementation of AI governance is imperative for excellent patient care.
Read moreHEDIS Measure Public Comment Period
This new measure will assess how well health plans ensure persons who screened positive for tobacco use received tobacco cessation intervention.
Read moreAMA Membership Amplifies College's Voice in House of Delegates
The ACR urges members to join or renew their membership in the American Medical Association by 3/15.
Read more